Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. (2022)
Attributed to:
Blood-brain barrier dysfunction and risk of dementia following blood-stream infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(22)00261-2
PubMed Identifier: 36075243
Publication URI: http://europepmc.org/abstract/MED/36075243
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Respiratory medicine
Issue: 12
ISSN: 2213-2600